FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16163011000001103: Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57097901000001114 Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57098001000001111 Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Is a Pramipexole 3.15mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has AMP Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start